Musings of a Cancer Doctor: My Backyard : Oncology Times
An abstract is unavailable.
An abstract is unavailable.
An abstract is unavailable.
In the first episode of A Deep Dive into HRD Testing in Ovarian Cancer, a three-part podcast series sponsored by AstraZeneca, we’ re speaking with…
This study aims to comprehensively analyze the clinicopathologic and molecular spectrum of NF1-mutant RMS compared with NF1-associated MTT for a better understanding of their pathogenesis.
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Our findings suggest that NF1 individuals may have a higher risk for developing melanomas and tend to have thicker melanomas and worse survival compared to…
An abstract is unavailable.
An abstract is unavailable.
An abstract is unavailable.
An abstract is unavailable.